These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3332914)

  • 21. Milacemide therapy for Parkinson's disease.
    Giuffra ME; Sethy VH; Davis TL; Mouradian MM; Chase TN
    Mov Disord; 1993; 8(1):47-50. PubMed ID: 8380487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC; Horstink MW; Roos RA; Jansen EN
    Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204
    [No Abstract]   [Full Text] [Related]  

  • 24. A trial of dextromethorphan in parkinsonian patients with motor response complications.
    Verhagen Metman L; Blanchet PJ; van den Munckhof P; Del Dotto P; Natté R; Chase TN
    Mov Disord; 1998 May; 13(3):414-7. PubMed ID: 9613730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance.
    Cedarbaum JM; Hoey M; McDowell FH
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):207-12. PubMed ID: 2649640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
    van der Drift JH
    Adv Neurol; 1987; 45():529-34. PubMed ID: 3825731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic comparison of Sinemet and Atamet (generic carbidopa/levodopa): a single-dose study.
    Pahwa R; Marjama J; McGuire D; Lyons K; Zwiebel F; Silverstein P; Ward R; Koller WC
    Mov Disord; 1996 Jul; 11(4):427-30. PubMed ID: 8813223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced Parkinson's disease: use of partial dopamine agonist, ciladopa.
    Lieberman A; Gopinathan G; Neophytides A; Pasternack P; Goldstein M
    Neurology; 1987 May; 37(5):863-5. PubMed ID: 3574692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease.
    De Michele G; Mengano A; Filla A; Trombetta L; Campanella G
    Acta Neurol (Napoli); 1989 Dec; 11(6):408-14. PubMed ID: 2694799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesulergine (CU32-085) in the treatment of Parkinson's disease.
    Pfeiffer RF; Wilken K; Glaeske C
    Ann Neurol; 1985 Apr; 17(4):334-6. PubMed ID: 3890700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained low-dose levodopa therapy in Parkinson's disease: a 3-year follow-up.
    Lees AJ; Stern GM
    Adv Neurol; 1983; 37():9-15. PubMed ID: 6858781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
    Bara-Jimenez W; Dimitrova T; Sherzai A; Favit A; Mouradian MM; Chase TN
    Mov Disord; 2004 Oct; 19(10):1183-6. PubMed ID: 15390018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T; Yahr MD
    Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
    Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
    Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease.
    Weiner WJ; Factor SA; Sanchez-Ramos JR
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):732-5. PubMed ID: 2746265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.
    Barbeau A; Roy M; Kastin AJ
    Can Med Assoc J; 1976 Jan; 114(2):120-2. PubMed ID: 3279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Piribedil in the treatment of Parkinson disease (author's transl)].
    Nardini M; Sciannandrone R; Fieschi C; De Simone G
    Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease: Cogentin with Sinemet, a better response.
    Tourtellotte WW; Potvin AR; Syndulko K; Hirsch SB; Gilden ER; Potvin JH; Hansch EC
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):51-5. PubMed ID: 7202230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.